Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Germaine™ Laboratories BioSign™ Flu A/B Kit
An In vitro rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.
$383.00 - $1914.00
Specifications
Content And Storage | 2°C to 30°C |
---|---|
CE Marker | Yes |
Clia Complexity | Waived (Nasal Swab) |
Detectable Analytes | Influenza A and B |
Includes | Positive and Negative Control Swabs |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
23-111-370
|
Germaine™ Laboratories
BSP51025P |
6 x 25 Kits = 150 Tests |
Case of 150 for $1,914.00
|
|
|||||
23-111-369
|
Germaine™ Laboratories
BSP51025 |
25 Tests |
Pack of 25 for $383.00
|
|
|||||
Description
- Differentiates between Influenza Type A & B, on a single test device
- Produces results in 10 to 15 minutes
- Each test device includes built-in controls
- Each kit comes with external controls
- Meets FDA performance criteria for influenza tests stated in code 21 CFR 866.3328
- CLIA Complexity: Moderate complexity when used with nasal wash/aspirate samples
- CLIA Waived when used with nasal and nasopharyngeal swabs
Specifications
2°C to 30°C | |
Waived (Nasal Swab) | |
Positive and Negative Control Swabs |
Yes | |
Influenza A and B |
Spot an opportunity for improvement?
Provide Content Correction
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title